Imidazo-triazine derivatives as ligands for GABA receptors

Details for Australian Patent Application No. 2002212530 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Hallett, David James; Van Niel, Monique Bodil; Street, Leslie Joseph; Russell, Michael Geoffrey Neil; Carling, William Robert; Bettati, Michela; Jennings, Andrew; Szekeres, Helen Jane; Lewis, Richard Thomas; Blurton, Peter; Chambers, Mark Stuart

Agent Spruson & Ferguson

Pub. Number AU-B-2002212530

PCT Pub. Number WO02/38568

Priority 0117277 16.07.01 GB; 0027562 10.11.00 GB

Filing date 8 November 2001

Wipo publication date 21 May 2002

Acceptance publication date 17 August 2006

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

17 August 2006 Application Accepted

  Published as AU-B-2002212530

14 December 2006 Standard Patent Sealed

2 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002212531

2002212529-Method of measuring platelet activation